Photo taken from Tom Powles/X
Jun 6, 2024, 10:02
Tom Powles: Great investigator-initiated study from LACOG and Fernando Maluf
Tom Powles, Director of Barts Cancer Center, shared a post on X:
“40% response rate for chemotherapy + pembro in advanced penile cancer.
(cORR 55.6%) and TMB-high (cORR 75%) potentially enrich. A great investigator-initiated study from LACOG and Fernando Maluf. ”
Source: Tom Powles/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48
Nov 13, 2024, 23:46